Invention Grant
- Patent Title: Anti-IL-22R antibodies
-
Application No.: US16661757Application Date: 2019-10-23
-
Publication No.: US11261246B2Publication Date: 2022-03-01
- Inventor: Christophe Frederic Jerome Blanchetot , Birgitte Ursø , Tine Skak-Nielsen , Malene Bertelsen , Sebastian Van Der Woning , Michael Saunders , Johannes Joseph Wilhelmus De Haard
- Applicant: argenx BVBA
- Applicant Address: BE Zwijnaarde
- Assignee: argenx BVBA
- Current Assignee: argenx BVBA
- Current Assignee Address: BE Zwijnaarde
- Agency: Lathrop GPM LLP
- Agent James H. Velema, Esq.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C12N15/62 ; A61K39/00 ; C07K16/24 ; A61P17/06 ; A61P19/02 ; A61P17/02 ; C07K14/54
Abstract:
The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.
Public/Granted literature
- US20200157207A1 ANTI-IL-22R ANTIBODIES Public/Granted day:2020-05-21
Information query
